Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BIS vs REW: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

REW Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 1–2 Matrix Metrics)

REW Overall Winner 6-Pillar Tally: BIS 0 – 0 REW (6 Tie) Matrix Metrics: BIS 2 – 1 REW

As of Nov 16, 2026, Proshares UltraShort Technology (REW) is the stronger overall head-to-head candidate over ProShares UltraShort NASDAQ Biotechnology (BIS) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BIS carries a Unified Composite Score of 54.1/100 (HOLD) at $11.11 (N/M Forward P/E, N/A operating margin), whereas REW carries 34.3/100 (SELL) at $13.99 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While BIS currently prints a higher short-term Unified Composite Score (54.1/100 HOLD vs. REW 34.3/100 SELL), REW captures the overall institutional head-to-head verdict (1–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BIS vs REW
BIS NASDAQ
ProShares UltraShort NASDAQ Biotechnology
Institutional Equity
$11.11
+4.21% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -1.39β · 60% Vol
Unified Composite Score
54.1 / 100 HOLD
Tech 90.0 Fund 65.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.8 · SMA20: $10.71 · SMA50: $11.29
REW NYSE Arca Head-to-Head Winner
Proshares UltraShort Technology
Institutional Equity
$13.99
+6.55% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -3.36β · 90% Vol
Unified Composite Score
34.3 / 100 SELL
Tech 8.0 Fund 31.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 63
RSI-14: 62.7 · SMA20: $12.37 · SMA50: $11.38

6-Pillar Scorecard Institutional Category Breakdown (BIS 0 – 0 REW)

Columns: Metric · BIS · REW
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 70.9% (100th %ile) 144.0% (50th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BIS (2) vs REW (1)
Institutional Metric BIS REW Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
30% ($8–$18) 93% ($5–$15) Stronger Trend REW
Beta / 30D Volatility
Risk Regime
-1.39β · 60% Vol -3.36β · 90% Vol Lower Realized Risk BIS
Unified Institutional Score
Composite Signal
54.1 / 100 (HOLD) 34.3 / 100 (SELL) Higher Composite BIS
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon REW +27.53 pp
BIS: -8.09% · REW: +19.44%
3M Horizon REW +28.34 pp
BIS: -7.96% · REW: +20.38%
6M Horizon REW +73.17 pp
BIS: +21.68% · REW: +94.85%
1Y Horizon REW +139.28 pp
BIS: +7.02% · REW: +146.3%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BIS vs REW. Trailing 12-month operating profitability (BIS N/A vs REW N/A) and valuation multiples (BIS N/M vs REW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BIS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
REW ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BIS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 70.9%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BIS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
REW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 144.0%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact REW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BIS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
REW Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BIS vs REW Key Questions & Quantitative Answers

As of Nov 16, 2026, Proshares UltraShort Technology (REW) is the stronger overall head-to-head candidate over ProShares UltraShort NASDAQ Biotechnology (BIS) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BIS carries a Unified Composite Score of 54.1/100 (HOLD) at $11.11 (N/M Forward P/E, N/A operating margin), whereas REW carries 34.3/100 (SELL) at $13.99 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While BIS currently prints a higher short-term Unified Composite Score (54.1/100 HOLD vs. REW 34.3/100 SELL), REW captures the overall institutional head-to-head verdict (1–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

BIS and REW split Growth & Scale metrics: BIS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with REW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BIS generates N/A in USD-normalized revenue versus N/A for REW. In operating R&D and SG&A reinvestment, BIS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for REW.

BIS and REW trade at balanced relative valuation multiples. BIS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas REW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BIS (N/A ROE) versus REW (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, BIS carries 70.9% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.39β · 60% Vol realized risk). By comparison, REW carries 144.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-3.36β · 90% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.